.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 8,114,885

« Back to Dashboard

Claims for Patent: 8,114,885

Title:Chemical compounds
Abstract: Pyrimidine derivatives, which are useful as VEGFR2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
Inventor(s): Boloor; Amogh (La Jolla, CA), Cheung; Mui (Wayne, PA), Harris; Philip Anthony (Wayne, PA), Hinkle; Kevin (Phoenixville, PA), Stafford; Jeffery Alan (San Diego, CA), Veal; James Marvin (Apex, NC)
Assignee: GlaxoSmithKline LLC (Philadelphia, PA)
Application Number:11/830,608
Patent Claims: 1. A compound of the formula: ##STR00124##

2. A pharmaceutical composition comprising an effective amount of an active ingredient, and one or more pharmaceutically acceptable carriers, diluents or excipients, wherein said active ingredient is 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-- 2-methylbenzenesulfonamide monohydrochloride.

3. The pharmaceutical composition of claim 2 wherein the pharmaceutical composition is for oral administration.

4. The pharmaceutical composition of claim 2, wherein said pharmaceutical composition comprises at least one diluent.

5. The pharmaceutical composition of claim 2 wherein said pharmaceutical composition comprising at least one excipient.

6. A pharmaceutical composition comprising: (i) at least one diluent; (ii) at least one disintegrant; and (iii) 5-({4-[(2H-indazol-6yl)methyl)amino]pyrimidin-2yl}amino)-2-methylbenzenes- ulfonamide monohydrochloride.

7. The pharmaceutical composition of claim 6 further comprising at least one lubricant.

8. A method of treating a disorder in a human, wherein said disorder is selected from the group consisting of colon cancer and breast cancer, said method comprising administering to said human an effective amount of a compound according to claim 1.

9. The method of claim 8, further comprising administering to said human at least one additional anti-cancer therapy.

10. The method of claim 9, wherein said additional anti-cancer therapy is a pharmaceutical active agent.

11. The method of claim 9, wherein said additional anti-cancer therapy is selected from the group consisting of surgical therapy and radiotherapy.

12. A method of treating a disorder in a human, wherein said disorder is selected from the group consisting of colon cancer and breast cancer, said method comprising administering to said human a pharmaceutical composition according to claim 2.

13. The method according to claim 12 wherein said disorder is breast cancer.

14. The method according to claim 12 wherein said disorder is colon cancer.

15. The method according to claim 8 wherein said disorder is breast cancer.

16. The method according to claim 8 wherein said disorder is colon cancer.

17. The pharmaceutical composition of claim 2 wherein the pharmaceutical composition is for oral administration, and wherein said pharmaceutical composition comprises at least one diluent.

18. The pharmaceutical composition of claim 2 wherein the pharmaceutical composition is for oral administration, wherein said pharmaceutical composition comprises at least one diluent, and wherein said pharmaceutical composition comprises at least one excipient.

19. The method of claim 15, further comprising administering to said human at least one additional anti-cancer therapy.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc